Results 221 to 230 of about 1,301,346 (361)
Photodynamic therapy (PDT) faces clinical challenges due to poor tumor targeting and systemic toxicity. Herein, a biomimetic C3N4‐RP@RBCm nanoplatform is developed via erythrocyte membrane encapsulation, enabling CD47‐mediated immune evasion and EPR‐driven tumor accumulation.
Jiaxiu Liu+9 more
wiley +1 more source
Mechanisms governing target search and binding dynamics of hypoxia-inducible factors. [PDF]
Chen Y+5 more
europepmc +1 more source
Expression of hypoxia-inducible factor 1: mechanisms and consequences
Gregg L. Semenza
openalex +1 more source
Expression of hypoxia-inducible factor-1α in oligodendrogliomas [PDF]
Peter Birner+7 more
openalex +1 more source
An Injection‐Molded Modified Silicone Rubber for Cancer‐on‐Chip Applications
This study describes the characterization and application of an injection‐molded functionalized PDMS fluidic insert for the commercially available Micronit system. Modified PDMS can accommodate cell culture and is able to covalently bind proteins for long‐lasting coatings under flow‐conditions.
Ben J. Haspels+7 more
wiley +1 more source
Renal tubular injury is a major contributor to kidney disease, yet remains poorly understood due to the lack of predictive models. This study presents a high‐throughput 3D renal proximal tubule model on the AngioPlate platform integrated with automated TEER measurements (AngioTEER), enabling real‐time monitoring of drug‐induced nephrotoxicity ...
Shravanthi Rajasekar+13 more
wiley +1 more source
Hypoxia-Inducible Factors and Diabetic Kidney Disease-How Deep Can We Go? [PDF]
Stanigut AM+5 more
europepmc +1 more source
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression [PDF]
Erik Laughner+4 more
openalex +1 more source
Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.
G. Semenza
semanticscholar +1 more source